To avoid overactive immune responses leading to excessive inflammatory responses and autoimmune diseases, the body has evolved immune checkpoint mechanisms to control the intensity and duration of immune responses and minimize the damage of immune responses to healthy tissues, mainly the CTLA4-B7 pathway and PD-1/PD-L1 pathway. Here, PDCD1 is linked to autoimmune disease.